Summarily, our results indicated that SLCO4A1-AS1 stabilized β-catenin by preventing the association between β-catenin and GSKβ, and consequently activated Wnt/β-catenin signaling in CRC. The gene discussed is SLCO4A1; the disease is colorectal carcinoma.